Insider · CIK 0001313403
Dominick Colangelo
ceopresidentofficerdirector
Files at VCEL (Vericel Corp), TRVI (Trevi Therapeutics, Inc.). First filing Oct 18, 2024, latest May 16, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 5
$0 bought, $9.0M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VCEL: Vericel Corp
VCELOct 9, 2026 · close 40.10
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 28Weak | Vericel Corp | $1.2M 28,125 shares | -10% | +12% from low-32% from high | |
| 20Weak | Vericel Corp | $2.1M 49,700 shares | -17% | +15% from low-28% from high | |
| 35Weak | Vericel Corp | $2.4M 53,183 shares | -19% | - | |
| 35Weak | Vericel Corp | $1.9M 35,000 shares | -15% | - | |
| 28Weak | Vericel Corp | $1.4M 35,000 shares | -15% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 11, 2025 | TRVI Trevi Therapeutics, Inc. | AGrant or award Nonstatutory Stock Option (right to buy)derivative | +45,000 | $0.00 | $0 | 45,000 | Jun 13, 2025 |
| May 14, 2025 | VCEL Vericel Corp | MOption exercise Common Stock10b5-1 | +14,062 | $2.65 | $37k | 274,416 | May 16, 2025 |
| May 14, 2025 | VCEL Vericel Corp | SOpen-market sale Common Stock10b5-1 | -14,062 | $42.25 | $594k | 260,354 | May 16, 2025 |
| May 15, 2025 | VCEL Vericel Corp | MOption exercise Common Stock10b5-1 | +14,063 | $2.65 | $37k | 274,417 | May 16, 2025 |
| May 15, 2025 | VCEL Vericel Corp | SOpen-market sale Common Stock10b5-1 | -14,063 | $41.53 | $584k | 260,354 | May 16, 2025 |
| May 14, 2025 | VCEL Vericel Corp | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | +14,062 | $0.00 | $0 | 14,063 | May 16, 2025 |
| May 15, 2025 | VCEL Vericel Corp | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | +14,063 | $0.00 | $0 | 0 | May 16, 2025 |
| Apr 9, 2025 | VCEL Vericel Corp | MOption exercise Common Stock10b5-1 | +24,850 | $2.75 | $68k | 285,204 | Apr 11, 2025 |
| Apr 9, 2025 | VCEL Vericel Corp | SOpen-market sale Common Stock10b5-1 | -24,850 | $41.11 | $1.0M | 260,354 | Apr 11, 2025 |
| Apr 10, 2025 | VCEL Vericel Corp | MOption exercise Common Stock10b5-1 | +24,850 | $2.75 | $68k | 285,204 | Apr 11, 2025 |
| Apr 10, 2025 | VCEL Vericel Corp | SOpen-market sale Common Stock10b5-1 | -24,850 | $41.89 | $1.0M | 260,354 | Apr 11, 2025 |
| Apr 9, 2025 | VCEL Vericel Corp | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | +24,850 | $0.00 | $0 | 24,850 | Apr 11, 2025 |
| Apr 10, 2025 | VCEL Vericel Corp | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | +24,850 | $0.00 | $0 | 0 | Apr 11, 2025 |
| Mar 12, 2025 | VCEL Vericel Corp | MOption exercise Common Stock10b5-1 | +26,591 | $1.95 | $52k | 286,588 | Mar 14, 2025 |
| Mar 12, 2025 | VCEL Vericel Corp | SOpen-market sale Common Stock10b5-1 | -26,591 | $46.31 | $1.2M | 259,997 | Mar 14, 2025 |
| Mar 13, 2025 | VCEL Vericel Corp | MOption exercise Common Stock10b5-1 | +26,592 | $1.95 | $52k | 286,589 | Mar 14, 2025 |
| Mar 13, 2025 | VCEL Vericel Corp | SOpen-market sale Common Stock10b5-1 | -26,592 | $45.78 | $1.2M | 259,997 | Mar 14, 2025 |
| Mar 12, 2025 | VCEL Vericel Corp | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | +26,591 | $0.00 | $0 | 26,592 | Mar 14, 2025 |
| Mar 13, 2025 | VCEL Vericel Corp | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | +26,592 | $0.00 | $0 | 0 | Mar 14, 2025 |
| Feb 24, 2025 | VCEL Vericel Corp | MOption exercise Common Stock | +18,250 | $0.00 | $0 | 268,456 | Feb 26, 2025 |
| Feb 24, 2025 | VCEL Vericel Corp | FTax withholding Common Stock | -8,459 | $52.33 | $443k | 259,997 | Feb 26, 2025 |
| Feb 24, 2025 | VCEL Vericel Corp | MOption exercise Restricted Stock Unitderivative | +18,250 | - | - | 54,750 | Feb 26, 2025 |
| Feb 20, 2025 | VCEL Vericel Corp | AGrant or award Stock Option (Right to Buy)derivative | +182,500 | $0.00 | $0 | 182,500 | Feb 24, 2025 |
| Feb 20, 2025 | VCEL Vericel Corp | AGrant or award Restricted Stock Unitderivative | +73,000 | $0.00 | $0 | 73,000 | Feb 24, 2025 |
| Feb 18, 2025 | VCEL Vericel Corp | MOption exercise Common Stock | +18,250 | - | - | 239,187 | Feb 20, 2025 |
| Feb 18, 2025 | VCEL Vericel Corp | MOption exercise Common Stock | +11,700 | $0.00 | $0 | 250,887 | Feb 20, 2025 |
| Feb 18, 2025 | VCEL Vericel Corp | FTax withholding Common Stock | -5,423 | $57.28 | $311k | 245,464 | Feb 20, 2025 |
| Feb 19, 2025 | VCEL Vericel Corp | MOption exercise Common Stock | +8,938 | $0.00 | $0 | 254,402 | Feb 20, 2025 |
| Feb 19, 2025 | VCEL Vericel Corp | FTax withholding Common Stock | -4,196 | $57.78 | $242k | 250,206 | Feb 20, 2025 |
| Feb 18, 2025 | VCEL Vericel Corp | MOption exercise Restricted Stock Unitderivative | +18,250 | - | - | 36,500 | Feb 20, 2025 |
| Feb 18, 2025 | VCEL Vericel Corp | MOption exercise Restricted Stock Unitderivative | +11,700 | - | - | 11,700 | Feb 20, 2025 |
| Feb 19, 2025 | VCEL Vericel Corp | MOption exercise Restricted Stock Unitderivative | +8,938 | - | - | 0 | Feb 20, 2025 |
| Nov 13, 2024 | VCEL Vericel Corp | MOption exercise Common Stock10b5-1 | +17,500 | $3.02 | $53k | 238,437 | Nov 15, 2024 |
| Nov 13, 2024 | VCEL Vericel Corp | SOpen-market sale Common Stock10b5-1 | -17,500 | $55.57 | $972k | 220,937 | Nov 15, 2024 |
| Nov 14, 2024 | VCEL Vericel Corp | MOption exercise Common Stock10b5-1 | +17,500 | $3.02 | $53k | 238,437 | Nov 15, 2024 |
| Nov 14, 2024 | VCEL Vericel Corp | SOpen-market sale Common Stock10b5-1 | -17,500 | $53.93 | $944k | 220,937 | Nov 15, 2024 |
| Nov 13, 2024 | VCEL Vericel Corp | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | +17,500 | $0.00 | $0 | 17,500 | Nov 15, 2024 |
| Nov 14, 2024 | VCEL Vericel Corp | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | +17,500 | $0.00 | $0 | 0 | Nov 15, 2024 |
| Oct 16, 2024 | VCEL Vericel Corp | MOption exercise Common Stock10b5-1 | +17,500 | $3.02 | $53k | 238,437 | Oct 18, 2024 |
| Oct 16, 2024 | VCEL Vericel Corp | SOpen-market sale Common Stock10b5-1 | -17,500 | $41.38 | $724k | 220,937 | Oct 18, 2024 |
| Oct 17, 2024 | VCEL Vericel Corp | MOption exercise Common Stock10b5-1 | +17,500 | $3.02 | $53k | 238,437 | Oct 18, 2024 |
| Oct 17, 2024 | VCEL Vericel Corp | SOpen-market sale Common Stock10b5-1 | -17,500 | $40.34 | $706k | 220,937 | Oct 18, 2024 |
| Oct 16, 2024 | VCEL Vericel Corp | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | +17,500 | $0.00 | $0 | 52,500 | Oct 18, 2024 |
| Oct 17, 2024 | VCEL Vericel Corp | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | +17,500 | $0.00 | $0 | 35,000 | Oct 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.